Elevated DHEA-S Levels May Shorten Lifespan in Men, No Impact Observed in Women
New genetic research links higher DHEA-S hormone levels to shorter lifespan in men, highlighting gender-specific health effects and raising questions about supplement regulation.
Recent research indicates a significant link between higher levels of the hormone dehydroepiandrosterone sulfate (DHEA-S) and reduced lifespan in men. The study, led by Professor Mary Schooling from CUNY School of Public Health, employed a Mendelian randomization approach, analyzing genetic data from large European cohorts to determine causal relationships while minimizing confounding factors.
The findings revealed that genetically higher DHEA-S levels are associated with increased blood pressure and a shorter lifespan among men. Interestingly, the same connection was not observed in women, suggesting a gender-specific effect.
DHEA-S is a precursor to male and female sex hormones, such as testosterone, which implies that elevated levels could influence health outcomes differently across genders. The study's results align with FDA warnings about testosterone therapy potentially increasing blood pressure in men. These insights raise important questions about the regulatory status and over-the-counter availability of DHEA supplements in the United States.
While the evidence on DHEA-S and lifespan has been limited, this study provides robust genetic data supporting its impact on men's health. Further research is needed to explore potential interventions and guideline considerations regarding DHEA supplementation.
Source: Medical Xpress
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Limited Access to Alzheimer's Treatments in Rural Georgia Raises Concerns
A new study reveals significant disparities in Alzheimer's treatment access for rural residents in Georgia, highlighting urgent healthcare inequities and the need for resource redistribution.
Many Patients on Ozempic, Wegovy, or Mounjaro Report Altered Taste Perceptions
A study presented at the EASD reveals that around 20% of patients on Ozempic, Wegovy, or Mounjaro experience heightened sensitivity to sweetness and saltiness, impacting appetite and weight loss outcomes.
Link Between Drinking Water, Food, and PFAS Exposure in California Adults
A new study from Boston University reveals that drinking water, seafood, eggs, and brown rice contribute to PFAS exposure in California adults, emphasizing the need for regulatory action and consumer awareness to reduce health risks.
Decline in Cardiac Arrest Survival Rates During Early COVID-19 Years
A recent study reveals that COVID-19’s early years led to decreased survival rates for out-of-hospital cardiac arrests, with notable racial and ethnic disparities persisting through 2022. Learn about the impact and ongoing challenges.